Grimes & Company, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Grimes & Company, Inc.
- $3.43 Billion
- Q4 2024
A detailed history of Grimes & Company, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Grimes & Company, Inc. holds 2,784 shares of XBI stock, worth $255,292. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,784
Previous 2,093
33.01%
Holding current value
$255,292
Previous $206,000
21.36%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding XBI
# of Institutions
912Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$1.02 Billion0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$933 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$876 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$781 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$734 Million0.06% of portfolio